Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MJCIG: THC Potency and Cigarette Smoking
NCT02961309Phase 1Completed
- Sponsor
- Battelle
- Start
- May 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol in Tobacco Use Disorder (TUD), sponsored by Battelle. Primary endpoint: Puff topography of tobacco cigarette smoked. Started May 2018; status: completed.
02
Drugs
dronabinol
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02961309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02961309.